Does comorbidity increase the risk of mortality among children under 3 years of age?

Christa L Fischer Walker1, Jamie Perin, Jodi L Liu

  • 1Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

BMJ Open
|August 23, 2013
PubMed

Insights

Comorbid diarrhea and acute lower respiratory infection (ALRI) in young children may increase mortality risk. While observed in South Asian studies, wider confidence intervals suggest more research is needed to confirm this link.

Area of Science:

  • Global Health
  • Pediatric Infectious Diseases
  • Epidemiology

Background:

  • Diarrhea and pneumonia are leading causes of death in children under five.
  • Limited data exists on the combined impact of comorbid diarrhea and pneumonia on child mortality.

Purpose of the Study:

  • To quantify the relationship between comorbid diarrhea and pneumonia infections and mortality risk in young South Asian children.
  • To analyze the additional mortality risk associated with simultaneous infections.

Main Methods:

  • Secondary data analysis of two prospective cohort studies in South Asia.
  • Inclusion of children under three years with regular morbidity assessments and mortality surveillance.
  • Utilized a semiparametric additive model to calculate mortality risks for single and comorbid infections.

Main Results:

  • An additional mortality risk was observed for comorbid diarrhea and acute lower respiratory infection (ALRI) in both Nepali (0.0014) and South Indian (0.0032) children.
  • This additional risk is separate from the mortality risk associated with each individual infection.
  • Confidence intervals for the additional risk were wide, indicating limited statistical power.

Conclusions:

  • Simultaneous diarrhea and ALRI episodes in young children are associated with an increased mortality risk.
  • The wide confidence intervals highlight the need for further, more powerful studies to confirm these findings.
  • Additional research is crucial to accurately estimate the effect size of comorbidity on child mortality.
Abstract

Keywords:
Public Health

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Causality in Epidemiology01:21

Causality in Epidemiology

Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...